Related Experiment Videos
Healing pressure ulcers with collagen or hydrocolloid: a randomized, controlled trial
James F Graumlich1, Linda S Blough, Richard G McLaughlin
1Department of Biomedical and Therapeutic Sciences and Medicine, University of Illinois College of Medicine, Peoria, Illinois 61605, USA. jfg@uic.edu
Journal of the American Geriatrics Society
|February 1, 2003
Summary
Topical collagen and hydrocolloid dressings showed similar effectiveness for pressure ulcer healing in a randomized trial. Hydrocolloid was more cost-effective, with collagen offering no significant advantages.
Area of Science:
- Wound healing research
- Dermatology
- Geriatric care
Background:
- Pressure ulcers represent a significant challenge in patient care, particularly in long-term facilities.
- Effective management strategies are crucial for improving patient outcomes and reducing healthcare costs.
Purpose of the Study:
- To compare the efficacy of topical collagen versus hydrocolloid dressings for healing Stage II and III pressure ulcers.
- To evaluate secondary outcomes including healing time, rate of healing, and cost-effectiveness.
Main Methods:
- A randomized, single-blind, controlled trial was conducted in eleven nursing homes.
- Sixty-five patients with Stage II or III pressure ulcers were randomized to receive either topical collagen daily or topical hydrocolloid twice weekly for 8 weeks.
- Outcomes included complete healing, time to heal, wound area healed per day, linear healing, and therapy cost.
Main Results:
- Complete ulcer healing rates were similar between collagen (51%) and hydrocolloid (50%) groups within 8 weeks.
- Mean healing times and rates of wound area healed per day were comparable for both treatments.
- Baseline ulcer depth was the only significant predictor of complete healing.
Conclusions:
- Topical collagen and hydrocolloid dressings demonstrate comparable efficacy in healing pressure ulcers.
- Hydrocolloid dressings were found to be more cost-effective than collagen.
- Collagen did not provide significant additional benefits for patients eligible for hydrocolloid treatment.